cangrelor and its Impurities
According to recent phase 3 randomized trials, a cangrelor–clopidogrel combination is safe and has been found to be more effective than standard clopidogrel treatment at reducing ischemic events in the heart, without increasing major bleeding in the treatment of stenotic coronary arteries. It is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug for intravenous application. Reference standards of Cangrelor API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
 
	
			                                  ![N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl) PA 30 91550](https://www.pharmaffiliates.com/pimages/PA3091550.jpg) 
																				N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-adenosine, 5'-(hydrogen P-1H-imidazol-1-ylphosphonate)
N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-adenosine, 5'-(hydrogen P-1H-imidazol-1-ylphosphonate)
- Catalogue No.:PA 30 91550 
- CAS : - 847460-53-1
- Molecular Formula : C16H23F3N5O7PS2 
- Molecular Weight : 549.48 
 
	
			                                   
																				((2R,3S,4R,5R)-3,4-Dihydroxy-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl hydrogen 1H-imidazol-1-ylphosphonate
((2R,3S,4R,5R)-3,4-Dihydroxy-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl hydrogen 1H-imidazol-1-ylphosphonate
- Catalogue No.:PA 30 91580 
- CAS : - 1054332-15-8
- Molecular Formula : C19H25F3N7O6PS2 
- Molecular Weight : 599.54 
 
	
			                                   
																				(2R,3R,4R,5R)-2-(6-Acetamido-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)-5-(acetoxymethyl)tetrahydrofuran-3,4-diyl Diacetate
(2R,3R,4R,5R)-2-(6-Acetamido-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)-5-(acetoxymethyl)tetrahydrofuran-3,4-diyl Diacetate
- Catalogue No.:PA 30 0911000 
- CAS : - 163706-52-3
- Molecular Formula : C21H24F3N5O8S 
- Molecular Weight : 563.51 
 
	
			                                   
																				(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-(N-(2-(methylthio)ethyl)acetamido)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl Diacetate
(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-(N-(2-(methylthio)ethyl)acetamido)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl Diacetate
- Catalogue No.:PA 30 0911001 
- CAS : - 163706-57-8
- Molecular Formula : C24H30F3N5O8S2 
- Molecular Weight : 637.65 
 
	
			                                   
																				((2S,3R,4S,5S)-3,4-Dihydroxy-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl Dihydrogen Phosphate
((2S,3R,4S,5S)-3,4-Dihydroxy-5-(6-((2-(methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl Dihydrogen Phosphate
- Catalogue No.:PA 30 0911004 
- CAS : - 2250335-99-8
- Molecular Formula : C16H23F3N5O7PS2 
- Molecular Weight : 549.48 
 
	
			                                   
																				N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-6-yl)-N-(2-(methylthio)ethyl)nitrous amide
N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-6-yl)-N-(2-(methylthio)ethyl)nitrous amide
- Catalogue No.:PA 30 0911008 
- CAS : - NA
- Molecular Formula : C16H21F3N6O5S2 
- Molecular Weight : 498.5 
 
	
			                                   
																				N-(2-(Methylsulfinyl)ethyl)-N-(9-nitroso-2-((3,3,3-trifluoropropyl)thio)-9H-purin-6-yl)nitrous amide
N-(2-(Methylsulfinyl)ethyl)-N-(9-nitroso-2-((3,3,3-trifluoropropyl)thio)-9H-purin-6-yl)nitrous amide
- Catalogue No.:PA 30 0911012 
- CAS : - NA
- Molecular Formula : C11H12F3N7O3S2 
- Molecular Weight : 411.38 
 
	
			                                   
																				((2R,3S,4R,5R)-3,4-Dihydroxy-5-(6-((2-(methylthio)ethyl)(nitroso)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl dihydrogen phosphate
((2R,3S,4R,5R)-3,4-Dihydroxy-5-(6-((2-(methylthio)ethyl)(nitroso)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl dihydrogen phosphate
- Catalogue No.:PA 30 0911013 
- CAS : - NA
- Molecular Formula : C16H22F3N6O8PS2 
- Molecular Weight : 578.47 
 
	
			                                   
																				N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-6-yl)-N-(2-(methylthio)ethyl)nitrous amide
N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-6-yl)-N-(2-(methylthio)ethyl)nitrous amide
- Catalogue No.:PA 30 0911014 
- CAS : - NA
- Molecular Formula : C16H21F3N6O5S2 
- Molecular Weight : 498.5 
 
	
			                                   
																				N-(2-(Methylthio)ethyl)-N-(9-nitroso-2-((3,3,3-trifluoropropyl)thio)-9H-purin-6-yl)nitrous amide
N-(2-(Methylthio)ethyl)-N-(9-nitroso-2-((3,3,3-trifluoropropyl)thio)-9H-purin-6-yl)nitrous amide
- Catalogue No.:PA 30 0911016 
- CAS : - NA
- Molecular Formula : C11H12F3N7O2S2 
- Molecular Weight : 395.38 

 
																				 
																				 
																				![2-[(3,3,3-Trifluoropropyl)thio]-adenosine PA 30 91530](https://www.pharmaffiliates.com/pimages/PA3091530.jpg) 
																				![N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl) PA 30 91540](https://www.pharmaffiliates.com/pimages/PA3091540.jpg) 
																				![N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl) PA 30 91560](https://www.pharmaffiliates.com/pimages/PA3091560.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
 
 
 
